TITLE

Long non-coding RNA MALAT-1 overexpression predicts tumor recurrence of hepatocellular carcinoma after liver transplantation

AUTHOR(S)
Lai, Ming-chun; Yang, Zhe; Zhou, Lin; Zhu, Qian-qian; Xie, Hai-yang; Zhang, Feng; Wu, Li-ming; Chen, Lei-ming; Zheng, Shu-sen
PUB. DATE
September 2012
SOURCE
Medical Oncology;Sep2012, Vol. 29 Issue 3, p1810
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Metastasis-associated lung adenocarcinoma transcript 1(MALAT1), a long non-coding RNA (lncRNA), is up-regulated in many solid tumors and associated with cancer metastasis and recurrence. However, its role in hepatocellular carcinoma (HCC) remains poorly understood. In the present study, we evaluated the expression of MALAT1 by quantitative real-time PCR in 9 liver cancer cell lines and 112 HCC cases including 60 cases who received liver transplantation (LT) with complete follow-up data. Moreover, small interfering RNA (siRNA) was used to inhibit MALAT1 expression to investigate its biological role in tumor progression. We found that MALAT1 was up-regulated in both cell lines and clinical tissue samples. Patients with high expression level of MALAT1 had a significantly increased risk of tumor recurrence after LT, particularly in patients who exceeded the Milan criteria. On multivariate analysis, MALAT1 was an independent prognostic factor for predicting HCC recurrence (hazard ratio, 3.280, P = 0.003).In addition, inhibition of MALAT1 in HepG2 cells could effectively reduce cell viability, motility, invasiveness, and increase the sensitivity to apoptosis. Our data suggest that lncRNA MALAT1 play an important role in tumor progression and could be a novel biomarker for predicting tumor recurrence after LT and serve as a promising therapeutic target.
ACCESSION #
79308895

 

Related Articles

  • p53, Ki-67, and serum alpha feto-protein as predictors of hepatocellular carcinoma recurrence in liver transplant patients. Guzman, Grace; Alagiozian-Angelova, Victoria; Layden-Almer, Jennifer E.; Layden, Thomas J.; Testa, Guiliano; Benedetti, Enrico; Kajdacsy-Balla, Andr&é; Cotler, Scott J. // Modern Pathology;Nov2005, Vol. 18 Issue 11, p1498 

    Patients with hepatocellular carcinoma who undergo orthotopic liver transplantation (OLT) are at risk for post-transplant tumor recurrence. The aim of this study was to evaluate whether expression of p53 and Ki-67 in hepatocellular carcinoma lesions present in explanted liver tissue was...

  • Role of Leukocyte Cell-Derived Chemotaxin 2 as a Biomarker in Hepatocellular Carcinoma. Okabe, Hirohisa; Delgado, Evan; Lee, Jung Min; Yang, Jing; Kinoshita, Hiroki; Hayashi, Hiromitsu; Tsung, Allan; Behari, Jaideep; Beppu, Toru; Baba, Hideo; Monga, Satdarshan P. // PLoS ONE;Jun2014, Vol. 9 Issue 6, p1 

    We sought to identify a secreted biomarker for β-catenin activation commonly seen in hepatocellular carcinoma (HCC). By examination of our previously published genearray of hepatocyte-specific β-catenin knockout (KO) livers, we identified secreted factors whose expression may be...

  • Identifying Prognostic Features by Bottom-Up Approach and Correlating to Drug Repositioning. Li, Wei; Yu, Jian; Lian, Baofeng; Sun, Han; Li, Jing; Zhang, Menghuan; Li, Ling; Li, Yixue; Liu, Qian; Xie, Lu // PLoS ONE;Mar2015, Vol. 10 Issue 3, p1 

    Background: Traditionally top-down method was used to identify prognostic features in cancer research. That is to say, differentially expressed genes usually in cancer versus normal were identified to see if they possess survival prediction power. The problem is that prognostic features...

  • Neutrophil-lymphocyte rations may predict HCC recurrence in liver transplant recipients.  // Hem/Onc Today;11/10/2012, Vol. 13 Issue 21, p23 

    The article reports on the results of a study concerning the rate of recurrence on patients with hepatocellular carcinoma who had neutrophil-lymphocyte ratios of 4 or greater following a liver transplant.

  • Genetic Variations in Plasma Circulating DNA of HBVRelated Hepatocellular Carcinoma Patients Predict Recurrence after Liver Transplantation. Jie Hu; Zheng Wang; Jia Fan; Zhi Dai; Yi-Feng He; Shuang-Jian Qiu; Xiao-Wu Huang; Jian Sun; Yong-Sheng Xiao; Kang Song; Ying-Hong Shi; Qi-Man Sun; Xin-Rong Yang; Guo-Ming Shi; Lei Yu; Guo-Huan Yang; Zhen-Bin Ding; Qiang Gao; Zhao-You Tang; Jian Zhou // PLoS ONE;2011, Vol. 6 Issue 10, p1 

    Background: Recurrence prediction of hepatitis B virus (HBV)-related hepatocellular carcinoma (HCC) patients undergoing liver transplantation (LT) present a great challenge because of a lack of biomarkers. Genetic variations play an important role in tumor development and metastasis. Methods:...

  • Repeated-Measures Implication of Hepatocellular Carcinoma Biomarkers in Living Donor Liver Transplantation. Chiu, King-Wah; Nakano, Toshiaki; Chen, Kuang-Den; Hsu, Li-Wen; Lai, Chia-Yun; Huang, Ching-Yin; Cheng, Yu-Fan; Goto, Shigeru; Chen, Chao-Long // PLoS ONE;May2015, Vol. 10 Issue 5, p1 

    Objective: Hepatocellular carcinoma (HCC) and its recurrence are major problems in living donor liver transplantation (LDLT). Several biomarkers have been used to investigate this event. We conducted a prospective controlled study to determine the activities of the basic fibroblast growth...

  • The Clinical Usefulness of Simultaneous Placement of Double Endoscopic Nasobiliary Biliary Drainage. Hong Jun Kim; Sung Koo Lee; Choong Heon Ryu; Do Hyun Park; Sang Soo Lee; Dong Wan Seo; Myung-Hwan Kim // Clinical Endoscopy;Nov2015, Vol. 48 Issue 6, p542 

    Background/Aims: To evaluate the technical feasibility and clinical efficacy of double endoscopic nasobiliary drainage (ENBD) as a new method of draining multiple bile duct obstructions. Methods: A total of 38 patients who underwent double ENBD between January 2004 and February 2010 at the Asan...

  • Longer transplant waits for HCC patients may be beneficial.  // Hem/Onc Today;12/10/2013, Vol. 14 Issue 23, p23 

    The article discusses a research study which suggested the benefit of longer transplant waits for patients with hepatocellular carcinoma (HCC), presented at The Liver Meeting held in Washington on November 1-5, 2013.

  • HPDI Table of Contents Vol. 13, No. 3, 2014.  // Digestive Surgery;Oct2014, Vol. 31 Issue 3, p243 

    No abstract available

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics